fosphenytoin will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

  • Vardenafil 5 mg may require dose adjustment based on response.
  • The medication can be combined with lifestyle changes for better results.
  • Commonly prescribed for men aged 40-70 years.
  • It is safe when used as directed under medical supervision.
  • Avoid grapefruit juice while taking Vardenafil 5 mg.
  • It can interact with certain antibiotics and antifungals.
  • Female partners should also be aware of medication effects.
  • The medication’s effectiveness depends on sexual stimulation.
  • Do not use Vardenafil 5 mg if you have a recent heart attack.
  • Be aware of possible visual disturbances as a side effect.
  • Emergency medical attention is needed if an erection lasts over 4 hours.
  • Proper hydration can help minimize side effects.

fostamatinibfostamatinib will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Usual Adult Dose for Erectile Dysfunction

Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors fosaprepitantfosaprepitant will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors fosaprepitant will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors fosfomycinfosfomycin and vardenafil both increase pills for men QTc interval. The risk of QT prolongation may increase in patients with electrolyte abnormalities (such as hypokalemia and hypocalcemia), patients with conditions that have potential to cause electrolyte imbalance (such as renal impairment), or patients taking other drugs affecting electrolyte balance or QT prolongation; avoid this drug in patients with known QT prolongation or ventricular arrhythmias, including a history of torsade de pointes; monitor electrolytes during treatment fosfomycin and vardenafil both increase QTc interval. The risk of QT prolongation may increase in patients with electrolyte abnormalities (such as hypokalemia and hypocalcemia), patients with conditions that have potential to cause electrolyte imbalance (such as renal impairment), or patients taking other drugs affecting electrolyte balance or QT prolongation; avoid this drug in patients with known QT prolongation or ventricular arrhythmias, including a history of torsade de pointes; monitor electrolytes during treatment fosphenytoinfosphenytoin will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors fostamatinib will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors fostemsavirvardenafil and fostemsavir both increase QTc interval. QTc prolongation reported with higher than recommended doses of fostemsavir.

  • Vardenafil 5 mg is not suitable for individuals taking certain heart medications.
  • The medication may cause dizziness or lightheadedness in some users.
  • Proper storage extends shelf life and maintains potency.
  • Lifestyle factors like stress can impact treatment success.
  • Avoid heavy meals before taking Vardenafil 5 mg to speed absorption.
  • The medication does not work without sexual stimulation.
  • Be aware of potential interactions with other prescribed drugs.
  • Patients should avoid driving if feeling dizzy after taking it.
  • Consult your doctor if you experience prolonged or painful erections.
  • Vardenafil 5 mg has a rapid onset but variable duration.
  • It is important to review medical history before starting therapy.
  • Combination therapy with other ED treatments should only be under medical supervision.

vardenafil and fostemsavir both increase QTc interval. gemifloxacingemifloxacin and vardenafil both increase QTc interval. gemifloxacin and vardenafil both increase QTc interval. gepirone and vardenafil both increase QTc interval. gepotidacingepotidacin increases levels of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Product Dosage Quantity + Bonus Price
Viagra Generic25mg10 Pills25.19€ 23.99€
Kamagra Soft Tabs100mg60 + 4 Pills180.59€ 171.99€
Kamagra Effervescent Tablets100 mg84 + 7 Pills202.91€ 193.25€
Kamagra Oral Jelly100 mg10 Sachets54.55€ 51.95€
Levitra Generic60mg10 Pills47.42€ 45.16€
Cialis Professional20mg60 + 2 Pills183.83€ 175.08€
Cialis Generic20mg270 + 10 Pills335.21€ 319.25€
Cialis Generic60mg10 Pills41.22€ 39.26€
Cialis Original20mg4 Pills41.99€ 39.99€
Levitra Original20mg12 Pills81.99€ 78.09€
Kamagra Polo100mg12 Pills60.21€ 57.34€
Viagra Professional100mg180 + 4 Pills337.30€ 321.24€
Cialis Generic2.5mg90 + 6 Pills112.43€ 107.08€
Viagra Generic150mg60 + 4 Pills111.25€ 105.95€

If possible, avoid with sensitive substrates that are are extensively metabolized by CYP3A4 and have a narrow therapeutic index.

Dosing & Uses

Limit vardenafil dose to 5 mg/24 hr erythromycin base will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Limit vardenafil dose to 5 mg/24 hr erythromycin lactobionateerythromycin lactobionate will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Limit fildena 100mg vardenafil dose to 5 mg/24 hr erythromycin stearateerythromycin stearate will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Limit vardenafil dose to 5 mg/24 hr erythromycin stearate will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Limit vardenafil dose to 5 mg/24 hr escitalopramescitalopram increases toxicity of vardenafil by QTc interval.

Key Takeaways

escitalopram increases toxicity of vardenafil by QTc interval. eslicarbazepine acetate will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Transient decrease in heart rate and AV conduction delays may occur when initiating etrasimod. Owing to potential of additive effect on heart rate, etrasimod may increase risk of QT prolongation and Torsades de Pointes when coadministered with Class Ia or Class III antiarrhythmic drugs, or other drugs that prolong the QT interval. etravirineetravirine will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Which drugs interact with vardenafil?

etravirine will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. fedratinibfedratinib will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors fedratinib will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors fexinidazolefexinidazole will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors fexinidazole will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. If unable to avoid, monitor or modify substrate dose according to its prescribing information.

Step Description Tips
Taking the medication Take orally with a glass of water Can be taken with or without food
Timing before sexual activity 30-60 minutes prior Avoid heavy fatty meal initially
Duration of effect Up to 4-5 hours, depending on individual Be aware of your response
Do not exceed prescribed dose Usually 5 mg per dose, once per day Overdose risks and side effects

gepotidacin increases levels of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. gilteritinib and vardenafil both increase QTc interval. granisetrongranisetron and vardenafil both increase QTc interval. granisetron and vardenafil both increase QTc interval. grapefruitgrapefruit will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. grapefruit will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

What other drugs will affect vardenafil?

Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors fingolimodfingolimod and vardenafil both increase QTc interval. fingolimod and vardenafil both increase QTc interval. fluconazolefluconazole will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors fluconazole will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors fludrocortisonefludrocortisone will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Visual disturbances

fludrocortisone will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. fluvoxaminefluvoxamine will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors fluvoxamine will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors fosamprenavirfosamprenavir will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors fosamprenavir will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. griseofulvingriseofulvin will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Concept Hierarchy & Relationship Mapping

Coadministration with duvelisib increases AUC of a sensitive CYP3A4 substrate which may increase the risk of toxicities of these drugs. Consider reducing the dose of the sensitive CYP3A4 substrate and monitor for signs of toxicities of the coadministered sensitive CYP3A substrate. duvelisib will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. efavirenzefavirenz will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.efavirenz and vardenafil both increase QTc interval.

What are the most common side effects of vardenafil?

efavirenz will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. elagolixelagolix decreases levels of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Consider increasing CYP3A substrate dose if needed. elagolix decreases levels of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Adjust vardenafil dose for ED; not to exceed single dose of 2.5 mg in 72 hr Encorafenib both inhibits and induces CYP3A4 at clinically relevant plasma concentrations.

Treatment & Diagnosis

Coadministration of encorafenib with sensitive CYP3A4 substrates may result in increased toxicity or decreased efficacy of these agents. Encorafenib both inhibits and induces CYP3A4 at clinically relevant plasma concentrations. entacaponeentacapone will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors entacapone will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors erythromycin baseerythromycin base will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. griseofulvin will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. haloperidolhaloperidol and vardenafil both increase QTc interval. haloperidol and vardenafil both increase QTc interval. hydrocortisonehydrocortisone will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

  • Vardenafil 5 mg is used to treat erectile dysfunction in men.
  • It works by increasing blood flow to the penis.
  • Vardenafil 5 mg usually starts working within 30-60 minutes.
  • The typical dosage for Vardenafil 5 mg is once daily.
  • It is available by prescription only.
  • Vardenafil 5 mg may cause side effects like headache or flushing.
  • It is more effective when taken on an empty stomach.
  • Alcohol can increase the risk of side effects with Vardenafil.
  • Do not take Vardenafil 5 mg with nitrates or certain medications.
  • Store Vardenafil 5 mg in a cool, dry place away from children.
  • Consult your doctor before starting Vardenafil 5 mg.
  • Report any persistent or severe side effects to your doctor.